GPCM
EPZM

Granite Point Capital Management’s Epizyme, Inc EPZM Stock Holding History

Granite Point Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,000
Closed -$579K – 108
2015
Q3 		$579K Hold
45,000
– – 0.4% 57
2015
Q2 		$1.08M Buy
+45,000
New +$866K 0.31% 46

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Granite Point Capital Management's EPZM Position: Q4 2015 in Review

Granite Point Capital Management sold out of Epizyme, Inc (EPZM) in Q4 2015, closing a stake of 45,000 shares — an estimated $579K sold.

Granite Point Capital Management first reported a position in EPZM in Q2 2015 and held it in 2 quarters. The position peaked at $1.08M in Q2 2015. 89 funds tracked by Wall St. Rank hold EPZM as of Q4 2015.

  • Granite Point Capital Management reported no remaining Epizyme, Inc position as of Q4 2015 after selling out during the quarter.
  • Granite Point Capital Management sold 45,000 Epizyme, Inc shares in Q4 2015, an estimated $579K.
  • Granite Point Capital Management first reported a position in Epizyme, Inc in Q2 2015 and held it in 2 quarters.
  • Granite Point Capital Management's Epizyme, Inc position peaked at $1.08M in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2015.

Based on Granite Point Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.